ARTICLE | Finance
Dermagraft redux
Advanced BioHealing proposes IPO to raise up to $200M
February 28, 2011 8:00 AM UTC
Profitable wound healing play Advanced BioHealing Inc. proposed late Friday to raise up to $200 million in an IPO.
The company markets Dermagraft, a human fibroblast-derived skin substitute, to treat full-thickness diabetic foot ulcers...